57 engineering-computation "https:" "https:" "https:" "https:" "https:" "UCL" "UCL" "UCL" positions at VIB in Belgium
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
Deadline 24 Aug 2026 - 23:59 (Europe/Brussels) Country Belgium Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is
-
validation, engineering, and valorization pathways such as licensing, partnerships, and spin‑outs. About the role We are seeking a Senior Computational Biology Scientist in AI Protein Structure Prediction and
-
12 Mar 2026 Job Information Organisation/Company VIB Research Field Biological sciences Computer science Researcher Profile Recognised Researcher (R2) Positions Other Positions Application Deadline
-
climate change, fostering sustainable agriculture, and preserving global biodiversity (https://www.psb.ugent.be/ ). In this respect, an important research topic of the center is the interaction between
-
Description We are seeking a motivated new PhD candidate who wants to join an exciting collaborative research program within the VIB-Center for Inflammation Research between the Guilliams, Saelens
-
in close partnership with the five universities in Flanders. The ICT department at VIB ensures that assets, technology, information, and data are managed securely and efficiently. Our focus includes
-
. How to apply Interested candidates should submit their candidacy through the VIB online application tool (https://jobs.vib.be/apply/133660 ). A complete application file (English) should contain
-
that accelerate innovation in healthcare and biotechnology through validation, engineering, and valorization pathways such as licensing, partnerships, and spin‑outs. About the role We are seeking a Computational
-
software engineering, computer science, data science, bioengineering, bioinformatics, engineering, physics or related Experience in either machine learning or computational biology. Interest in both
-
) and ATTR (transthyretin) amyloidosis are the most common systemic forms, with distinct molecular origins but shared mechanisms of extracellular amyloid deposition and tissue damage. Our research program